Form 4 Tracker
James V Cassella

Chief Development Officer · 1 filing · Latest: Feb 19, 2026

Trevi Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
James V Cassella — Insider Trading Activity | LevelFields AI